Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MicroSafe Care Australia is a healthcare company specializing in advanced infection control and wound management solutions. The company utilizes a proprietary, pH-neutral electrolyzed water technology, known as Microcyn, to produce high-level disinfectants and wound care products that are non-toxic and environmentally friendly. Their product range is designed for use in hospitals, clinics, and aged care facilities to eliminate a broad spectrum of pathogens, including bacteria, viruses, and fungi, without causing irritation or promoting antimicrobial resistance. MicroSafe's solutions are TGA-approved in Australia and are recognized for their efficacy in biofilm removal and rapid wound healing. The company serves as a key provider of medical-grade disinfection technology across the Oceania region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MicroSafe Care Australia.